Effect of static magnetic field therapy on diabetic neuropathy and quality of life: a double-blind, randomized trial

Table 3 Comparison of outcome measure mean values in two groups

Outcome measure	Magnet (n = 32) Mean ± SD	Sham (n = 32) Mean ± SD	P value
NSS:
Baseline	13 ± 1.88	12.63 ± 2.09	0.50
4 weeks	10.22 ± 2.82	12.66 ± 2.05	< 0.001^a
8 weeks	6.25 ± 2.68	12.66 ± 2.05	< 0.001^a
12 weeks	2.78 ± 2.61	12.50 ± 2.00	< 0.001^a
VAS:
Baseline	6.28 ± 2.30	5.47 ± 2.47	0.17
4 weeks	4.03 ± 2.20	5.34 ± 2.59	0.03^a
8 weeks	2.50 ± 1.88	5.34 ± 2.54	< 0.001^a
12 weeks	0.63 ± 0.94	5.28 ± 2.58	< 0.001^a
NDS:
Baseline	6.84 ± 1.83	6.53 ± 1.54	0.74
12 weeks	4.47 ± 1.36	6.53 ± 1.54	< 0.001^a
NeuroQol:
Baseline	66.97 ± 15.92	67.88 ± 16.65	0.17
12 weeks	35.56 ± 4.47	71.47 ± 15.46	< 0.001^a

ISSN: 1758-5996